SCHEMBL9299084

SCHEMBL9299084

CO[C@H]1O[C@H](CBr)[C@@H](OC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@@H]1F

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 13/20 0.42
▸ LGALS3 P17931 2/20 0.41
▸ LGALS9 O00182 1/20 0.41
▸ LGALS1 P09382 1/20 0.41
▸ LGALS7; LGALS7B P47929 1/20 0.41
▸ LGALS4 P56470 1/20 0.39
▸ PTPN2 P17706 2/20 0.37
▸ PTPN6 P29350 2/20 0.37
▸ PTPN11 Q06124 2/20 0.37
▸ LGALS8 O00214 1/20 0.37
▸ SELP P16109 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5620161 0.90 PTPN1 (0.48) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL5620156 0.90 PTPN1 (0.48) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL14428941 0.88 PTPN1 (0.49) PTPN1PTPN2PTPN11
SCHEMBL14568615 0.88 PTPN1 (0.49) PTPN1PTPN2PTPN11
SCHEMBL6908883 0.88 PTPN1 (0.45) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL6907757 0.85 LGALS8 (0.47) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL14601934 0.85 LGALS8 (0.47) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL7147800 0.84 LGALS3 (0.47) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL7149488 0.84 LGALS3 (0.47) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B
SCHEMBL7147794 0.84 LGALS3 (0.47) PTPN1LGALS3LGALS9LGALS1LGALS7; LGALS7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374746-A L-talopyranoside derivatives and process for the preparation of same DONG-A PHARMACEUTICAL CO., LTD. (KR) 1994-12-20 — — US disclosed
Send feedback